Aug 9 |
What Makes Street Analysts Bullish on Regeneron Pharmaceuticals, Inc. (REGN) Now?
|
Aug 8 |
3 Biotech Stocks With Promising Drug Pipelines: August 2024
|
Aug 7 |
Regeneron Announces Investor Conference Presentations and Oncology Investor Webcast
|
Aug 7 |
3 Healthcare Stocks Positioned for Possible Market Outperformance
|
Aug 7 |
Regeneron: Expanded Product Base Taking Root, More Is Certainly On The Way
|
Aug 6 |
Nvidia, Meta, Netflix Profit Outlooks Sunny Despite Harsh Selling
|
Aug 5 |
Google's search monopoly, El-Erian talks the Fed: Market Domination
|
Aug 5 |
Investing in biotech outside of weight-loss drugs
|
Aug 5 |
Regeneron (REGN) Q2 Earnings Gain From Eylea HD, Dupixent
|
Aug 3 |
Is Regeneron Pharmaceuticals Due for a Stock Split?
|